TCM-808FB

N/A

Report date: 2023/05/22 10:16:32

Base Information

Drug NameTCM-808FB
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionImmunoglobulin modulators
TargetsImmunoglobulin
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTcm Biotech International Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A